Regulatory Action Is Lesser Of Firms' Worries Amid Class-Action Blitz

摘要

In the current U.S. legal environment, class-action suits have surpassed FDA action as the greatest threat to cosmetic firms whose claims are perceived as misleading or out of bounds, attorneys suggested at the American Confer-ence Institute's Legal, Regulatory and Compliance Forum on Cosmetics in New York.